SCHEMBL18637326

SCHEMBL18637326

N#CB1CCC(O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19562614 0.71 GPR119 (0.35) —
SCHEMBL23486737 0.70 CHRNB2 (0.42) —
SCHEMBL24754156 0.69 ESR2 (0.32) —
SCHEMBL24890582 0.69 — —
SCHEMBL22995951 0.69 — —
SCHEMBL23486409 0.67 — —
SCHEMBL24289456 0.67 — —
SCHEMBL18461890 0.65 — —
SCHEMBL23288610 0.65 TP53 (0.41) —
SCHEMBL23486494 0.65 DPP4 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760855-B1 SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AS WELL AS THEIR USE IN TREATING TYPE-2 DIABETES MERCK SHARP & DOHME (US) 2017-03-15 — — EP disclosed
Send feedback